Merck
-
Merck appoints Pratima Reddy as MD for Merck Specialities
Reddy has an extensive experience of over 17 years, with nine years in the pharmaceutical industry Merck announced the appointment…
Read More » -
Merck’s microbiology application lab opens in Jigani, Bengaluru
Supports capability built-up in microbial quality control in Pharma, and biopharma industry Merck invests €200,000 in the infrastructure of the…
Read More » -
MSD ties up with five pharma majors in India for molnupiravir
Molnupiravir is an investigational oral antiviral agent currently being studied in a Phase 3 trial for the treatment of non-hospitalised…
Read More » -
Merck reports topline data for bintrafusp alfa for cancer treatment
In the study of 159 patients, bintrafusp alfa demonstrated single-agent efficacy and durability with a manageable safety profile after more…
Read More » -
Merck announces update on INTR@PID Lung 037 study
The comprehensive INTR@PID programme is designed to assess the impact of bintrafusp alfa across distinct cancers Merck, Darmstadt, Germany, announced…
Read More » -
Merck acquires AmpTec
The company will expand mRNA capabilities for vaccines, treatments and diagnostics Merck announced the acquisition of AmpTec, a leading Hamburg,…
Read More » -
Merck divests stake in vaccine-maker Moderna
Merck expects to record a small gain from the sale in the fourth quarter of 2020 US drugmaker Merck &…
Read More » -
Serum Institute, IAVI, Merck to develop COVID-19 treatment
Monoclonal antibodies will be developed to fight COVID-19 and to ensure their prompt and equitable global access Non-profit scientific research…
Read More »